Spironolactone improves angiotensin-induced vascular changes and oxidative stress
- PMID: 12364354
- DOI: 10.1161/01.hyp.0000034738.79310.06
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
Abstract
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II-induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12/group) received angiotensin II (120 ng/kg per minute, subcutaneously) for 14 days +/- spironolactone or hydralazine (25 mg/kg per day). An additional group received aldosterone (750 ng/h, subcutaneously) +/- spironolactone. Systolic blood pressure was increased by angiotensin II (P<0.001) and reduced by spironolactone and hydralazine (P<0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (P<0.05). In mesenteric small arteries studied on a pressurized myograph, media/lumen ratio was increased (P<0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II-infused rats (P<0.001); both were partially improved by spironolactone (P<0.05) but not by hydralazine. Aldosterone-induced increase of media/lumen ratio (P<0.001) and impaired response to acetylcholine (P<0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (P<0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (P<0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid-reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (P<0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II-induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II-induced vascular effects in hypertension, in part via increased oxidative stress.
Similar articles
-
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.Hypertension. 2003 Jul;42(1):49-55. doi: 10.1161/01.HYP.0000078357.92682.EC. Epub 2003 Jun 2. Hypertension. 2003. PMID: 12782645
-
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.J Hypertens. 2003 Jan;21(1):189-98. doi: 10.1097/00004872-200301000-00029. J Hypertens. 2003. PMID: 12544451
-
PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.Hypertension. 2002 Dec;40(6):866-71. doi: 10.1161/01.hyp.0000037969.41360.cc. Hypertension. 2002. PMID: 12468571
-
[Role of aldosterone in oxidative stress and renal injury].Yakugaku Zasshi. 2007 Sep;127(9):1331-7. doi: 10.1248/yakushi.127.1331. Yakugaku Zasshi. 2007. PMID: 17827915 Review. Japanese.
-
Aldosterone: a risk factor for vascular disease.Curr Hypertens Rep. 2003 Feb;5(1):59-65. doi: 10.1007/s11906-003-0012-2. Curr Hypertens Rep. 2003. PMID: 12530937 Review.
Cited by
-
Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.Br J Pharmacol. 2013 Feb;168(3):519-33. doi: 10.1111/j.1476-5381.2012.02194.x. Br J Pharmacol. 2013. PMID: 23190073 Free PMC article. Review.
-
Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase.J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):353-9. doi: 10.1177/1470320312443911. Epub 2012 May 3. J Renin Angiotensin Aldosterone Syst. 2012. PMID: 22554826 Free PMC article.
-
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Endocrinology. 2010 Jan;151(1):322-31. doi: 10.1210/en.2009-0806. Epub 2009 Oct 22. Endocrinology. 2010. PMID: 19850745 Free PMC article.
-
Macro- and micronutrients in African-Americans with heart failure.Heart Fail Rev. 2006 Mar;11(1):45-55. doi: 10.1007/s10741-006-9192-6. Heart Fail Rev. 2006. PMID: 16819577 Review.
-
Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.Heart Fail Rev. 2005 Jan;10(1):31-7. doi: 10.1007/s10741-005-2346-0. Heart Fail Rev. 2005. PMID: 15947889 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources